The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis

Timothy S. Johnson, Martin Griffin, Graham L. Thomas, N. Skill, Ann Cox, Bin Yang, Ben Nicholas, Paul J. Birckbichler, Chiwoneso Muchaneta-Kubara, A. Meguid El Nahas

Research output: Contribution to journalArticle

109 Citations (Scopus)

Abstract

Tissue transglutaminase is a calcium-dependent enzyme that catalyzes the cross-linking of polypeptide chains, including those of extracellular matrix (ECM) proteins, through the formation of ε-(γ-glutamyl) lysine bonds. This cross-linking leads to the formation of protein polymers that are highly resistant to degradation. As a consequence, the enzyme has been implicated in the deposition of ECM protein in fibrotic diseases such as pulmonary fibrosis and atherosclerosis. In this study, we have investigated the involvement of tissue transglutaminase in the development of kidney fibrosis in adult male Wistar rats submitted to subtotal nephrectomy (SNx). Groups of six rats were killed on days 7, 30, 90, and 120 after SNx. As previously described, these rats developed progressive glomerulosclerosis and tubulo-interstitial fibrosis. The tissue level of ε-(γ-glutamyl) lysine cross-link (as determined by exhaustive proteolytic digestion followed by cation exchange chromatography) increased from 3.47± 0.94 (mean±SEM) in controls to 13.24±1.43 nmol/g protein 90 d after SNx, P ≤ 0.01. Levels of ε-(γ- glutamyl) lysine cross-link correlated well with the renal fibrosis score throughout the 120 observation days (r = 0.78, P ≤ 0.01). Tissue homogenates showed no significant change in overall transglutaminase activity (14C putrescine incorporation assay) unless adjusted for the loss of viable tubule cells, when an increase from 5.77±0.35 to 13.93±4.21 U/mg DNA in cytosolic tissue transglutaminase activity was seen. This increase was supported by Western blot analysis, showing a parallel increase in renal tissue transglutaminase content. Immunohistochemistry demonstrated that this large increase in ε-(γ-glutamyl) lysine cross-link and tissue transglutaminase took place predominantly in the cytoplasm of tubular cells, while immunofluorescence also showed low levels of the ε-(γ-glutamyl) lysine cross-link in the extracellular renal interstitial space. The number of cells showing increases in tissue transglutaminase and its cross-link product. ε- (γ-glutamyl) lysine appeared greater than those showing signs of typical apoptosis as determined by in situ end-labeling. This observed association between tissue transglutaminase, ε-(γ-glutamyl) lysine cross-link, and renal tubulointerstitial scarring in rats submitted to SNx suggests that tissue transglutaminase may play an important role in the development of experimental renal fibrosis and the associated loss of tubule integrity.

Original languageEnglish (US)
Pages (from-to)2950-2960
Number of pages11
JournalJournal of Clinical Investigation
Volume99
Issue number12
StatePublished - Jun 15 1997
Externally publishedYes

Fingerprint

Transglutaminases
Nephrectomy
Fibrosis
Lysine
Kidney
Extracellular Matrix Proteins
Putrescine
transglutaminase 2
Pulmonary Fibrosis
Enzymes
Cicatrix
Fluorescent Antibody Technique
Cations
Chromatography
Wistar Rats
Digestion
Atherosclerosis
Polymers
Cytoplasm
Proteins

Keywords

  • ε-(γ-glutamyl) lysine
  • Kidney
  • Scarring
  • Subtotal nephrectomy
  • Tubule

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Johnson, T. S., Griffin, M., Thomas, G. L., Skill, N., Cox, A., Yang, B., ... El Nahas, A. M. (1997). The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis. Journal of Clinical Investigation, 99(12), 2950-2960.

The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis. / Johnson, Timothy S.; Griffin, Martin; Thomas, Graham L.; Skill, N.; Cox, Ann; Yang, Bin; Nicholas, Ben; Birckbichler, Paul J.; Muchaneta-Kubara, Chiwoneso; El Nahas, A. Meguid.

In: Journal of Clinical Investigation, Vol. 99, No. 12, 15.06.1997, p. 2950-2960.

Research output: Contribution to journalArticle

Johnson, TS, Griffin, M, Thomas, GL, Skill, N, Cox, A, Yang, B, Nicholas, B, Birckbichler, PJ, Muchaneta-Kubara, C & El Nahas, AM 1997, 'The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis', Journal of Clinical Investigation, vol. 99, no. 12, pp. 2950-2960.
Johnson TS, Griffin M, Thomas GL, Skill N, Cox A, Yang B et al. The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis. Journal of Clinical Investigation. 1997 Jun 15;99(12):2950-2960.
Johnson, Timothy S. ; Griffin, Martin ; Thomas, Graham L. ; Skill, N. ; Cox, Ann ; Yang, Bin ; Nicholas, Ben ; Birckbichler, Paul J. ; Muchaneta-Kubara, Chiwoneso ; El Nahas, A. Meguid. / The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis. In: Journal of Clinical Investigation. 1997 ; Vol. 99, No. 12. pp. 2950-2960.
@article{568eb89024b24b21a2cedf3e91fab72f,
title = "The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis",
abstract = "Tissue transglutaminase is a calcium-dependent enzyme that catalyzes the cross-linking of polypeptide chains, including those of extracellular matrix (ECM) proteins, through the formation of ε-(γ-glutamyl) lysine bonds. This cross-linking leads to the formation of protein polymers that are highly resistant to degradation. As a consequence, the enzyme has been implicated in the deposition of ECM protein in fibrotic diseases such as pulmonary fibrosis and atherosclerosis. In this study, we have investigated the involvement of tissue transglutaminase in the development of kidney fibrosis in adult male Wistar rats submitted to subtotal nephrectomy (SNx). Groups of six rats were killed on days 7, 30, 90, and 120 after SNx. As previously described, these rats developed progressive glomerulosclerosis and tubulo-interstitial fibrosis. The tissue level of ε-(γ-glutamyl) lysine cross-link (as determined by exhaustive proteolytic digestion followed by cation exchange chromatography) increased from 3.47± 0.94 (mean±SEM) in controls to 13.24±1.43 nmol/g protein 90 d after SNx, P ≤ 0.01. Levels of ε-(γ- glutamyl) lysine cross-link correlated well with the renal fibrosis score throughout the 120 observation days (r = 0.78, P ≤ 0.01). Tissue homogenates showed no significant change in overall transglutaminase activity (14C putrescine incorporation assay) unless adjusted for the loss of viable tubule cells, when an increase from 5.77±0.35 to 13.93±4.21 U/mg DNA in cytosolic tissue transglutaminase activity was seen. This increase was supported by Western blot analysis, showing a parallel increase in renal tissue transglutaminase content. Immunohistochemistry demonstrated that this large increase in ε-(γ-glutamyl) lysine cross-link and tissue transglutaminase took place predominantly in the cytoplasm of tubular cells, while immunofluorescence also showed low levels of the ε-(γ-glutamyl) lysine cross-link in the extracellular renal interstitial space. The number of cells showing increases in tissue transglutaminase and its cross-link product. ε- (γ-glutamyl) lysine appeared greater than those showing signs of typical apoptosis as determined by in situ end-labeling. This observed association between tissue transglutaminase, ε-(γ-glutamyl) lysine cross-link, and renal tubulointerstitial scarring in rats submitted to SNx suggests that tissue transglutaminase may play an important role in the development of experimental renal fibrosis and the associated loss of tubule integrity.",
keywords = "ε-(γ-glutamyl) lysine, Kidney, Scarring, Subtotal nephrectomy, Tubule",
author = "Johnson, {Timothy S.} and Martin Griffin and Thomas, {Graham L.} and N. Skill and Ann Cox and Bin Yang and Ben Nicholas and Birckbichler, {Paul J.} and Chiwoneso Muchaneta-Kubara and {El Nahas}, {A. Meguid}",
year = "1997",
month = "6",
day = "15",
language = "English (US)",
volume = "99",
pages = "2950--2960",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "12",

}

TY - JOUR

T1 - The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis

AU - Johnson, Timothy S.

AU - Griffin, Martin

AU - Thomas, Graham L.

AU - Skill, N.

AU - Cox, Ann

AU - Yang, Bin

AU - Nicholas, Ben

AU - Birckbichler, Paul J.

AU - Muchaneta-Kubara, Chiwoneso

AU - El Nahas, A. Meguid

PY - 1997/6/15

Y1 - 1997/6/15

N2 - Tissue transglutaminase is a calcium-dependent enzyme that catalyzes the cross-linking of polypeptide chains, including those of extracellular matrix (ECM) proteins, through the formation of ε-(γ-glutamyl) lysine bonds. This cross-linking leads to the formation of protein polymers that are highly resistant to degradation. As a consequence, the enzyme has been implicated in the deposition of ECM protein in fibrotic diseases such as pulmonary fibrosis and atherosclerosis. In this study, we have investigated the involvement of tissue transglutaminase in the development of kidney fibrosis in adult male Wistar rats submitted to subtotal nephrectomy (SNx). Groups of six rats were killed on days 7, 30, 90, and 120 after SNx. As previously described, these rats developed progressive glomerulosclerosis and tubulo-interstitial fibrosis. The tissue level of ε-(γ-glutamyl) lysine cross-link (as determined by exhaustive proteolytic digestion followed by cation exchange chromatography) increased from 3.47± 0.94 (mean±SEM) in controls to 13.24±1.43 nmol/g protein 90 d after SNx, P ≤ 0.01. Levels of ε-(γ- glutamyl) lysine cross-link correlated well with the renal fibrosis score throughout the 120 observation days (r = 0.78, P ≤ 0.01). Tissue homogenates showed no significant change in overall transglutaminase activity (14C putrescine incorporation assay) unless adjusted for the loss of viable tubule cells, when an increase from 5.77±0.35 to 13.93±4.21 U/mg DNA in cytosolic tissue transglutaminase activity was seen. This increase was supported by Western blot analysis, showing a parallel increase in renal tissue transglutaminase content. Immunohistochemistry demonstrated that this large increase in ε-(γ-glutamyl) lysine cross-link and tissue transglutaminase took place predominantly in the cytoplasm of tubular cells, while immunofluorescence also showed low levels of the ε-(γ-glutamyl) lysine cross-link in the extracellular renal interstitial space. The number of cells showing increases in tissue transglutaminase and its cross-link product. ε- (γ-glutamyl) lysine appeared greater than those showing signs of typical apoptosis as determined by in situ end-labeling. This observed association between tissue transglutaminase, ε-(γ-glutamyl) lysine cross-link, and renal tubulointerstitial scarring in rats submitted to SNx suggests that tissue transglutaminase may play an important role in the development of experimental renal fibrosis and the associated loss of tubule integrity.

AB - Tissue transglutaminase is a calcium-dependent enzyme that catalyzes the cross-linking of polypeptide chains, including those of extracellular matrix (ECM) proteins, through the formation of ε-(γ-glutamyl) lysine bonds. This cross-linking leads to the formation of protein polymers that are highly resistant to degradation. As a consequence, the enzyme has been implicated in the deposition of ECM protein in fibrotic diseases such as pulmonary fibrosis and atherosclerosis. In this study, we have investigated the involvement of tissue transglutaminase in the development of kidney fibrosis in adult male Wistar rats submitted to subtotal nephrectomy (SNx). Groups of six rats were killed on days 7, 30, 90, and 120 after SNx. As previously described, these rats developed progressive glomerulosclerosis and tubulo-interstitial fibrosis. The tissue level of ε-(γ-glutamyl) lysine cross-link (as determined by exhaustive proteolytic digestion followed by cation exchange chromatography) increased from 3.47± 0.94 (mean±SEM) in controls to 13.24±1.43 nmol/g protein 90 d after SNx, P ≤ 0.01. Levels of ε-(γ- glutamyl) lysine cross-link correlated well with the renal fibrosis score throughout the 120 observation days (r = 0.78, P ≤ 0.01). Tissue homogenates showed no significant change in overall transglutaminase activity (14C putrescine incorporation assay) unless adjusted for the loss of viable tubule cells, when an increase from 5.77±0.35 to 13.93±4.21 U/mg DNA in cytosolic tissue transglutaminase activity was seen. This increase was supported by Western blot analysis, showing a parallel increase in renal tissue transglutaminase content. Immunohistochemistry demonstrated that this large increase in ε-(γ-glutamyl) lysine cross-link and tissue transglutaminase took place predominantly in the cytoplasm of tubular cells, while immunofluorescence also showed low levels of the ε-(γ-glutamyl) lysine cross-link in the extracellular renal interstitial space. The number of cells showing increases in tissue transglutaminase and its cross-link product. ε- (γ-glutamyl) lysine appeared greater than those showing signs of typical apoptosis as determined by in situ end-labeling. This observed association between tissue transglutaminase, ε-(γ-glutamyl) lysine cross-link, and renal tubulointerstitial scarring in rats submitted to SNx suggests that tissue transglutaminase may play an important role in the development of experimental renal fibrosis and the associated loss of tubule integrity.

KW - ε-(γ-glutamyl) lysine

KW - Kidney

KW - Scarring

KW - Subtotal nephrectomy

KW - Tubule

UR - http://www.scopus.com/inward/record.url?scp=0030986772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030986772&partnerID=8YFLogxK

M3 - Article

VL - 99

SP - 2950

EP - 2960

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 12

ER -